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ABSTRACT 
 
The Effects of Peritoneal Dialysis Fluid and its Components on the Differentiation of 
White Blood Cells into Fibrocytes. 
 (May 2012) 
 
Hannah Elizabeth Starke 
Department of Biology 
Texas A&M University 
 
Research Advisor: Dr. Richard Gomer 
Department of Biology 
 
Kidneys filter out toxins which accumulate in the blood.  In order to replace the function 
of the kidneys in patients with kidney damage, fluid is injected into the abdominal 
cavity, and after 4-8 hours, during which the fluid has collected waste products, the fluid 
is removed.  This process is called peritoneal dialysis or PD.  Though effective in 
detoxification, PD can come with a grave side effect: the formation of scar tissue in the 
abdomen.  To form this scar tissue, white blood cells leave the blood and develop into 
cells called fibrocytes.  A blood protein called Serum Amyloid P (SAP) inhibits the 
development of fibrocytes. I investigated how the dialysis fluid and its separate salt 
components affect the development of fibrocytes. I found that dialysis fluid and its 
component salts sodium chloride and sodium lactate all caused significant increases in 
human fibrocyte development in tissue culture.   I then tested the effect of PD fluid and 
its components on the ability of SAP to inhibit fibrocyte development.  I found that 
whole PD fluid and sodium lactate decreased the ability of SAP to inhibit the 
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development of fibrocytes.  These results show that components of PD fluid enhance the 
development of fibrocytes, which could provide an explanation for the development of 
scar tissue during dialysis treatment.   
.   
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NOMENCLATURE 
 
PD  Peritoneal Dialysis 
CAPD  Continuous Ambulatory Peritoneal Dialysis 
RPMI  Roswell Park Memorial Institute Medium 
PBMC  Peripheral Blood Mononuclear Cells 
SAP  Serum Amyloid P  
GDP   Glucose Degradation Products  
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CHAPTER I 
INTRODUCTION 
 
Project purpose  
This report serves to describe my research. I sought to determine if dialysis fluid and its 
components enhance the formation of fibrocytes, to understand why scar tissue develops 
in the abdominal cavity during PD treatment. 
 
Peritoneal dialysis  
During late stage kidney diseases, human kidneys no longer perform their function of 
cleaning toxins out of the blood.  In most cases, physicians use dialysis to replace that 
function [1].  The most common form of dialysis is known as hemodialysis which is 
performed by running a person’s blood through an external machine to clean the blood 
of waste and biological by-products; however, during late stage kidney failure, 
continuous ambulatory peritoneal dialysis (CAPD) commonly replaces hemodialysis as a 
treatment to remove toxins.  With CAPD, dialysis fluid is injected into the abdominal 
cavity via a permanent catheter, and after 4-8 hours, during which it has collected waste 
products, it is removed and replaced with more fluid [2,3] (Figure 1) 
_______________ 
This thesis follows the style of PLos ONE. 
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.   
 
 
 
 
 
Peritoneal Dialysis fluids contain a mixture of electrolytes to help maintain blood 
composition, an osmotic agent to facilitate the transport of water and other liquids 
through a membrane, and a buffer to maintain proper pH. A commonly used peritoneal 
dialysis fluid named Dianeal contains the electrolytes sodium, chloride, calcium, and 
magnesium, the sugar D-glucose as an osmolyte, and a buffer containing lactate [4].   
 
Although this hemodialysis alternative provides less expensive treatment, a more mobile 
lifestyle, and at-home sessions, one serious drawback exists: the potential to develop a 
debilitating, deadly disease called peritoneal fibrosis. Although progression into fibrosis 
occurs in approximately 1% of patients, understanding why fibrosis develops could 
allow us to develop dialysis fluids that do not cause fibrosis [5].  Glucose degradation 
products (GDP) (including 5-hydroxymethylfuraldehyde and 3,4-dideoxyglucosone-3-
ene) that form during heat sterilization of the PD fluid have an adverse effect and can 
Figure 1: Schematic of peritoneal dialysis. Courtesy of Baxter Healthcare 
Corporation 
http://www.livenow.info/DiscoverHome/DiscoverPD/PDisDifferent/Differ
entProcess.aspx 
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promote fibrosis, but researchers have not investigated the effects of other components 
[6]. 
 
Fibrosis and fibrocytes 
Fibrosis refers to the formation of unhealthy fibrous scar tissue in an organ or tissue. 
During an immune response, the body recruits white blood cells to the affected area to 
repair damage.  These cells aid in the destruction of invaders and the formation of scar 
tissue.  However, when the body recruits white blood cells to an area where no injury 
has occurred, the resulting response can hinder the biological functions of the area [5].  
This unnecessary recruitment of fibrocytes can begin the development of a fibrosing 
disease. Common fibrosing diseases include heart disease, liver cirrhosis, scleroderma, 
and Crohn’s Disease along with many other well known autoimmune diseases.  These 
diseases can lead to the degradation of an organ or tissue system and eventual death of 
the individual [7].   
 
Fibrosis is characterized by the presence of white blood cell-derived cells called 
fibrocytes.  Fibrocytes promote wound healing by aiding in the creation of fibrous scar 
tissue [8].  They are visually characterized by being long, spindle-shaped cells with an 
oval-shaped nucleus (Figure 2).  Fibrocytes have a combination of blood cells markers 
and connective tissue cell markers which distinguishes them from other white blood 
cells [9,10]. These markers include CD45, CD14, CD90, and a variety of collagen 
markers [9].   
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SAP 
Serum Amyloid Protein P (SAP) circulates in the blood and inhibits the differentiation of 
white blood cells into fibrocytes [8].  While SAP levels in the blood are at normal levels, 
around 32 + 7 μg/mL for men and 24 + 7 μg/mL for women [8], normal wound healing 
and related functions can occur.  When those levels begin to decrease or the activity of 
SAP declines, fibrocytes become more prevalent and can cause damage to internal 
processes or diseases like fibrosis.  The exact mechanism of how SAP inhibits fibrocyte 
differentiation has not been determined.  
   
The determination of what compounds affect the number of fibrocytes that develop, and 
the effect those compounds have on the functioning of SAP are both important concepts 
to investigate.  Finding an explanation for scar tissue formation could lead to improved 
Figure 2: White blood cells dyed with eosin and methylene blue.  
“a” indicates fibrocyte. 
a
. 
 
60μm 
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treatment options which would decrease fibrosis seen in patients receiving PD.  These 
alternative treatments would save many lives.  
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CHAPTER II 
MATERIALS AND METHODS 
 
Cell culture and fibrocyte differentiation assay 
We collected blood from voluntary adult donors in agreement with Texas A&M 
University’s Institutional Review Board. We isolated peripheral blood mononuclear cells 
(PBMC) as previously described by Pilling et al. [11].  
 
PD fluid contains the following concentrations of ions: 132 mM sodium, 96 mM 
chloride, 3.5 mM calcium, 0.5 mM magnesium, 40 mM lactate, and 1.5% dextrose. I 
added these concentrations to water to make PD fluid.  I also made solutions of sodium 
chloride, calcium chloride, magnesium chloride, sodium lactate, and dextrose to test the 
individual components.   
 
I cultured PBMC in Falcon 96-well cell culture plates to test the effect that varying 
concentrations of peritoneal dialysis fluid and the separate components had on the 
differentiation of fibrocytes in RPMI medium. For PD fluid, I added 200μL of PD fluid 
in the first well followed by 100μL of RPMI in the following seven wells.  For the 
individual salts, I added 200μL RPMI and twice the concentration of salt found in PD 
fluid into the first well and 100μL RPMI to the following seven wells. I then used serial 
dilutions to create a range of concentrations by transferring 100μL from one well to next 
and disposing of the last 100μL. I used two rows of serial dilutions for each salt tested, 
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and each plate has a row of RPMI with no added salt as a control. 50,000 cells in 100μL 
of RPMI were added to each well, halving the concentration in the well by doubling the 
volume. Cells were incubated for five days at 5% CO2 and 37°C.  Following the 
incubation period, I fixed cells to the plate for ten minutes using methanol and then 
stained cells for ninety seconds with each of the two dyes eosin and methylene blue. 
 
I counted fibrocytes in five different 900-μm fields of view. My analysis was done using 
the percent of fibrocytes found in the experimental wells relative to the average of the 
control wells (RPMI medium with no added salts).  I performed t-tests using GraphPad 
Prism software to determine the statistical significance of increased fibrocyte numbers 
compared to control.  
 
SAP dilution  
I performed SAP dilutions ranging from 5μg/mL to 0.04μg/mL in RPMI medium, 12.5% 
PD fluid in RPMI, 12.5mM sodium chloride added to RPMI, and 5mM sodium lactate 
added to RPMI.  I used the same PBMC isolation and assay procedure as before.  I 
compared SAP dilution curves of the salts to that of the RPMI medium alone, and with 
those curves, I found and compared each condition’s IC 50 value. These values signify 
the concentration of SAP which causes 50% differentiation of fibrocytes. I performed    
t-tests using GraphPad Prism software to determine the statistical significance between 
IC50 values. 
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Immunohistochemistry 
I used immunohistochemistry to stain for immunological markers on the white blood 
cells as previously described [11].  I used this staining to verify that the cells I found 
were fibrocytes.  I stained samples with mouse and rat antibodies specific for the cell 
markers CD 45, CD 68, procollagen, and prolyl-4-hydroxylase.   
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CHAPTER III 
RESULTS 
 
Component salts effect on differentiation 
Products of glucose degradation which form during sterilization of glucose solutions can 
cause an increased development of scar tissue [6]. I wanted to determine if peritoneal 
dialysis fluid affects the differentiaiton of PBMC into fibrocytes.  I found that PD fluid 
caused a statistically significant (p<0.001) increase around 12.5% in the 200 µl in vitro 
cell cultures (Figure 3). Percentages above 12.5% caused cell death. 
 
 
 
 
 
 
Figure 3: PD fluid potentiates the differentiation of fibrocytes from white blood 
cells. White blood cells were incubated with the indicated concentrations of PD fluid 
for 5 days. The cells were then stained and counted. Values are mean ± SEM, n=6. 
12.5% fluid showed the largest increase in fibrocyte differentiation when compared to 
the control. This increase was statistically significant (* indicates statistical 
significance, p<0.001). This x-axis is in a logarithmic scale. 
 
* 
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To determine whether specific components of PD fluid cause the increase in fibrocyte 
differentiation caused by whole PD fluid, I cultured PBMC in individual compounds of 
the dialysis fluid (sodium chloride, sodium lactate, magnesium chloride, calcium 
chloride, and dextrose).  The fibrocyte differentiation increase seen at 12.5 mM sodium 
chloride (Figure 4) and 5 mM sodium lactate (Figure 5) are statistically significant 
(p<0.001).  These concentrations correlate to the 12.5% conventional PD fluid that 
increased fibrocyte differentiation. Calcium chloride (Figure 6), magnesium chloride 
(Figure 7), and dextrose (Figure 8) showed no statistically significant increases (p>0.05). 
Upper testing limits for sodium chloride, sodium lactate, calcium chloride and dextrose 
were dictated both by concentrations found in the PD fluid and concentrations above 
which cells died. Previous research performed by Katayoon Keyhanian showed similar 
results with slightly different conditions.  
 
 
 
 
             
 
 
 
 
 
Figure 4: Sodium chloride causes a statistically significant increase in fibrocyte 
differentiation. White blood cells were incubated with the indicated concentrations 
of sodium chloride for 5 days, after which cells were stained and counted. Values are 
mean ± SEM n=3. Sodium chloride caused a statistically significant (p<0.001) 
increase of fibrocyte numbers at 12.5 mM (peak indicated by *). This x-axis is in a 
logarithmic scale. 
* 
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Figure 5: Sodium lactate causes a statistically significant increase in fibrocyte 
differentiation. White blood cells were incubated with the indicated concentrations 
of sodium lactate for 5 days, after which cells were stained and counted. Values are 
mean ± SEM n=3. Sodium lactate caused a statistically significant (p<0.001) increase  
of fibrocyte umbers at 5 mM (peak indicated by *). This x-axis is in a logarithmic 
scale. 
Figure 6:  Calcium chloride causes no statistically significant increases in fibrocyte 
differentiation. White blood cells were incubated with the indicated concentrations of 
calcium chloride for 5 days, after which cells were stained and counted. Values are 
mean ± SEM n=3. Calcium chloride caused no statistically significant increases in 
fibrocyte differentiation. This x-axis is in a logarithmic scale. The absence of an error 
bar indicates that the error was smaller than the plot symbol. 
* 
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Figure 7: Magnesium chloride causes no statistically significant increases in 
fibrocyte differentiation. White blood cells were incubated with the indicated 
concentrations of magnesium chloride for 5 days, after which cells were stained and 
counted. Values are mean ± SEM n=3. Magnesium chloride caused no statistically 
significant increases in fibrocyte differentiation. This x-axis is in a logarithmic scale. 
Figure 8: Dextrose causes no statistically significant increases in fibrocyte 
differentiation. White blood cells were incubated with the indicated concentrations of 
dextrose for 5 days, after which cells were stained and counted. Values are mean ± SEM 
n=3. Dextrose caused no statistically significant increases in fibrocyte differentiation. 
This x-axis is in a logarithmic scale. The absence of an error bar indicates that the error 
was smaller than the plot symbol. 
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Effects of component salts on the sensitivity of SAP  
SAP inhibits fibrocyte differentiation. I sought to determine if salts found in PD fluid 
lower the effectiveness of SAP by desensitizing the PBMC to SAP. The desensitization 
would further enhance the formation of fibrocytes. I used the concentrations of salts I 
found to have the largest effect on fibrocyte differentiation to test the effect they had on 
the activity of SAP.  
 
IC50 values tell the concentration at which you observe 50% differentiation of 
fibrocytes. An increase in IC50 value compared to the control signifies desensitization. I 
observed that PD fluid, sodium chloride, and sodium lactate all decreased the ability of 
SAP to inhibit fibrocyte differentiation (Figure 9).  PD fluid and sodium lactate both had 
statistically significant increases of the SAP IC50 (Table 1). 
 
 
Solution IC50 (mean ± SEM) 
Control 0.13±0.03 μg/ml 
Peritoneal Dialysis Fluid (PD)  0.31±0.03 μg/ml 
Sodium Chloride 0.26±0.05 μg/ml 
Sodium Lactate 0.32±0.06 μg/ml 
 
Table 1: IC50 Values of PD fluid, sodium chloride and sodium lactate. Increase in IC50 
value compared to control indicates desensitization. Statistically significant increases were 
observed for PD fluid and sodium lactate (p<0.05). 
  14 
  
 
 
 
 
 
 
Immunohistochemistry  
Fibrocytes display antibody markers for both stromal and hematopoietic cells. To certfiy 
that I found fibrocytes, I stained the cultured cells using antibodies that recognize 
fibrocyte markers. Staining for markers CD 45, CD 68, Prolyly-4-hydroxylase, and 
procollagen showed positive results, indicating that the cells that I counted as fibrocytes 
were indeed fibrocytes.  
Figure 9: PD fluid, NaCl, and Na lactate desensitize the white blood cells to the 
effects of SAP. The response of white blood cells to increasing concentrations of SAP 
was investigated in the presence of PD fluid, NaCl, and Na lactate. All the added 
solutions caused a decrease in the sensitivity of white blood cells to SAP. I found that 
whole PD fluid, sodium chloride, and sodium lactate decreased the ability of SAP to 
inhibit the development of fibrocytes. 
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
 
I found that dialysis fluid and its component salts sodium chloride and sodium lactate 
caused significant increase in human fibrocyte formation in tissue culture compared to 
the control (RPMI). All of these statistically significant increases occurred around 12.5% 
of the concentrations found in whole fluid. This increase in fibrocyte formation could 
provide one explanation for scar tissue development in the abdominal cavity.  
 
I then tested the effect of PD fluid and its components on the ability of SAP to inhibit 
fibrocyte differentiation.    IC50 values tell the concentration at which you observe 50% 
differentiation of fibrocytes.  The increase in IC50 values of the salts compared to that of 
the control indicates a desensitization of the white blood cells to SAP. This 
desensitization of PBMC to SAP provides a second explanation for why PD fluid 
potentiates scar tissue formation.  
 
These results show that components of PD fluid enhance the development of fibrocytes. 
It accomplishes this both by promoting the development of fibrocytes and desensitizing 
cells to the inhibiting protein SAP. Together, these results could provide an explanation 
for the development of peritoneal scar tissue during dialysis treatment. 
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In the future, research could focus on how to change the composition of the dialysis fluid 
to decrease the development of fibrocytes. Different salts or fluid composition could 
reduce the risk of fibrosis development in patients receiving PD.   
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